• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Dynamic changes of neutralizing antibody and memory T cell responses six months post Omicron XBB reinfection

tetano

Editor, Senior Moderator
Front Immunol


. 2024 Oct 7:15:1477721.
doi: 10.3389/fimmu.2024.1477721. eCollection 2024. Dynamic changes of neutralizing antibody and memory T cell responses six months post Omicron XBB reinfection

Xin-Jing Zhao[SUP] #[/SUP][SUP] 1 2 [/SUP], Xin-Lou Li[SUP] #[/SUP][SUP] 3 [/SUP], Sheng Zhang[SUP] 1 [/SUP], Jin-Jin Chen[SUP] 1 [/SUP], Wei-Chao Zhao[SUP] 4 [/SUP], Na-Na Wu[SUP] 4 [/SUP], Rui-Juan Wang[SUP] 4 [/SUP], Qiang Xu[SUP] 1 [/SUP], Chen-Long Lv[SUP] 1 [/SUP], Bao-Gui Jiang[SUP] 1 [/SUP], Guo-Lin Wang[SUP] 1 [/SUP], Li-Qun Fang[SUP] 1 2 [/SUP]



Affiliations
Abstract

Introduction: With the continued prevalence of COVID-19, repeated infection caused by SARS-CoV-2 has become common. However, studies on immune persistence post Omicron XBB reinfection are limited.
Methods: We prospectively studied the durability and cross-reactivity of neutralizing antibodies (NAbs) and T cell responses among 20 subjects who suffered Omicron BA.5 infection with or without Omicron XBB reinfection over 6-month through the pseudovirus neutralization test and the fluorospot assay.
Results: NAbs against EG.5.1, BA.2.86, and JN.1 subvariants were decreased and undetectable at 6-month post Omicron BA.5 infection, while those elicited by Omicron XBB reinfection were significant increased and remained detectable against all detected variants within 6-month. Furthermore, in subjects with Omicron XBB reinfection, memory T cell responses could cross-recognized wild-type and Omicron spike peptides and reached peak at 3-month. Interestingly, comparable robust T cell responses were observed among non-seroconverted subjects post Omicron XBB exposure.
Conclusion: Though the NAbs against various emerging Omicron subvariants elicited by Omicron XBB reinfection can persist for at least 6-month, the HCWs should strengthen personal protection and timely be immunized with updated vaccines upon current circulating variants or conserved T epitope.

Keywords: Omicron XBB reinfection; cross-recognition; immune persistence; memory T cell responses; neutralizing antibody.

 
Back
Top Bottom